vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and KAMADA LTD (KMDA). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $47.0M, roughly 2.0× KAMADA LTD). KAMADA LTD runs the higher net margin — 11.3% vs -98.1%, a 109.3% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 12.6%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 12.0%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma.

HIVE vs KMDA — Head-to-Head

Bigger by revenue
HIVE
HIVE
2.0× larger
HIVE
$93.1M
$47.0M
KMDA
Growing faster (revenue YoY)
HIVE
HIVE
+205.9% gap
HIVE
218.6%
12.6%
KMDA
Higher net margin
KMDA
KMDA
109.3% more per $
KMDA
11.3%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
12.0%
KMDA

Income Statement — Q3 FY2026 vs Q3 FY2025

Metric
HIVE
HIVE
KMDA
KMDA
Revenue
$93.1M
$47.0M
Net Profit
$-91.3M
$5.3M
Gross Margin
-27.1%
42.0%
Operating Margin
16.6%
Net Margin
-98.1%
11.3%
Revenue YoY
218.6%
12.6%
Net Profit YoY
-234.0%
37.1%
EPS (diluted)
$-0.38
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
KMDA
KMDA
Q4 25
$93.1M
Q3 25
$87.3M
$47.0M
Q2 25
$45.6M
$44.8M
Q1 25
$44.0M
Q4 24
$29.2M
Q3 24
$22.6M
$41.7M
Q2 24
$32.2M
$42.5M
Q1 24
$37.7M
Net Profit
HIVE
HIVE
KMDA
KMDA
Q4 25
$-91.3M
Q3 25
$-15.8M
$5.3M
Q2 25
$35.0M
$7.4M
Q1 25
$4.0M
Q4 24
$68.2M
Q3 24
$80.0K
$3.9M
Q2 24
$-18.3M
$4.4M
Q1 24
$2.4M
Gross Margin
HIVE
HIVE
KMDA
KMDA
Q4 25
-27.1%
Q3 25
4.7%
42.0%
Q2 25
-13.6%
42.3%
Q1 25
47.1%
Q4 24
-43.7%
Q3 24
-66.1%
41.3%
Q2 24
-7.4%
44.6%
Q1 24
44.4%
Operating Margin
HIVE
HIVE
KMDA
KMDA
Q4 25
Q3 25
16.6%
Q2 25
15.8%
Q1 25
17.7%
Q4 24
Q3 24
12.7%
Q2 24
13.3%
Q1 24
10.7%
Net Margin
HIVE
HIVE
KMDA
KMDA
Q4 25
-98.1%
Q3 25
-18.1%
11.3%
Q2 25
76.8%
16.5%
Q1 25
9.0%
Q4 24
233.2%
Q3 24
0.4%
9.3%
Q2 24
-56.7%
10.4%
Q1 24
6.3%
EPS (diluted)
HIVE
HIVE
KMDA
KMDA
Q4 25
$-0.38
Q3 25
$-0.07
$0.09
Q2 25
$0.18
$0.13
Q1 25
$0.07
Q4 24
$0.52
Q3 24
$0.00
$0.07
Q2 24
$-0.17
$0.08
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
KMDA
KMDA
Cash + ST InvestmentsLiquidity on hand
$72.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$265.2M
Total Assets
$624.0M
$377.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
KMDA
KMDA
Q4 25
Q3 25
$72.0M
Q2 25
$66.0M
Q1 25
$76.3M
Q4 24
$40.5M
Q3 24
$31.7M
$72.0M
Q2 24
$56.5M
Q1 24
$48.2M
Stockholders' Equity
HIVE
HIVE
KMDA
KMDA
Q4 25
$559.3M
Q3 25
$624.6M
$265.2M
Q2 25
$560.5M
$260.0M
Q1 25
$252.0M
Q4 24
$430.9M
Q3 24
$275.5M
$255.3M
Q2 24
$268.6M
$251.2M
Q1 24
$251.2M
Total Assets
HIVE
HIVE
KMDA
KMDA
Q4 25
$624.0M
Q3 25
$693.0M
$377.2M
Q2 25
$628.7M
$368.2M
Q1 25
$375.1M
Q4 24
$478.6M
Q3 24
$334.7M
$351.2M
Q2 24
$351.0M
Q1 24
$343.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
KMDA
KMDA
Operating Cash FlowLast quarter
$46.0M
$10.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.97×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
KMDA
KMDA
Q4 25
$46.0M
Q3 25
$-10.6M
$10.4M
Q2 25
$10.2M
$8.0M
Q1 25
$-513.0K
Q4 24
$-28.5M
Q3 24
$-2.2M
$22.2M
Q2 24
$-4.4M
$14.0M
Q1 24
$1.0M
Free Cash Flow
HIVE
HIVE
KMDA
KMDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-55.5M
Q3 24
$-34.7M
Q2 24
Q1 24
FCF Margin
HIVE
HIVE
KMDA
KMDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-189.9%
Q3 24
-153.4%
Q2 24
Q1 24
Capex Intensity
HIVE
HIVE
KMDA
KMDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
92.5%
Q3 24
143.9%
Q2 24
Q1 24
Cash Conversion
HIVE
HIVE
KMDA
KMDA
Q4 25
Q3 25
1.97×
Q2 25
0.29×
1.09×
Q1 25
-0.13×
Q4 24
-0.42×
Q3 24
-26.94×
5.75×
Q2 24
3.15×
Q1 24
0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons